Full-Time

Medical Affairs Leader

Dyslipidemia

Deadline 7/31/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

Compensation Overview

$193k - $289k/yr

+ Short-term incentive bonus + Equity-based long-term incentive program

Gaithersburg, MD, USA

Hybrid

Minimum of three days per week in the office.

Category
🩺Medical, Clinical & Veterinary (1)
Requirements
  • Masters degree with 3-5 years of experience in the pharmaceutical industry (Medical, Marketing, R&D, Market Access roles), or experience working within a relevant health system setting (clinical, pharmacy, pathway design, etc.)
  • Demonstration of strategic and medical leadership prowess pre- and post- product launch, including ability to define evidence needs, create compelling scientific narratives & strategy, influence & mobilize others
  • Experience/expertise in CVRM therapy areas, especially lipids and cardiovascular prevention
  • Ability to analyze patient pathways and take patient perspective
Responsibilities
  • Creating & communicating world-class medical content and compelling science narratives for products/market-shaping initiatives
  • Shaping/designing evidence needs and clinical studies to differentiate or expand market access for AstraZeneca medicines and in support healthcare change initiatives
  • Driving an ambitious external engagement agenda – credible and knowledgeable with an ability to partner with/mobilise global thought leaders, societies, health organisations and health system decision-makers
  • Delivering prerequisites for an outstanding product launch – strategy, scientific narrative, Key Performance Indicators (KPIs) – with an ability to critically assess performance against launch objectives and proactively take remedial action
  • Creating new opportunities to drive market growth, identifying, and scaling best-practices across countries
  • Collaborating cross functionally to drive the delivery of strategically important resources as well as scientifically accurate & compliant commercial materials
Desired Qualifications
  • Doctoral level degree: MD, PhD, or PharmD
  • Strong working relationships with global clinical thought leaders, professional societies and other healthcare industries/organizations
  • Experience of delivering results in a complex environment
  • Experience launching new products or indications in global or within large markets (US/CN/JP/EU5)
  • Proven ability to build internal and external networks and to collaborate
  • Vulgarization and storytelling skills
  • Experience with digital and healthcare tools
  • Evidence generation experience—working on clinical trials or real-world evidence program

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatments; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery boosts precision biologics development with Sortera Bio.
  • Expansion in Bangalore strengthens AstraZeneca's presence in emerging markets.
  • Partnership with Danaher advances precision medicine diagnostics.

What critics are saying

  • Increased competition in oncology from Bristol-Myers Squibb and Merck.
  • Patent expirations, like Symbicort, threaten revenue with potential generic competition.
  • Regulatory challenges in China could hinder AstraZeneca's growth prospects.

What makes AstraZeneca unique

  • AstraZeneca's Open Innovation program accelerates drug discovery through shared resources.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Strategic partnerships enhance AstraZeneca's research capabilities and product portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

CardioPhoenix
Jul 11th, 2025
Heart Health in 10 Minutes: Cardio-HART Saves Lives at "Diagnósticos F.C.", AstraZeneca

Last week, Cardio-Phoenix partnered with AstraZeneca for a transformative day of community heart-health screening at the "Diagnósticos F.C." event held at the BAKH Sports Center in Vitoria.

HRKatha
Jun 27th, 2025
AstraZeneca creates 400 jobs, expands its global hub in Bangalore

AstraZeneca creates 400 jobs, expands its global hub in Bangalore.

Devdiscourse
Jun 18th, 2025
AstraZeneca's Stake in Niox Group: A Strategic Partnership | Headlines

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move signals strategic collaboration opportunities between the two companies, potentially aligning their interests in the pharmaceutical industry and expanding their influence in the sector.

InfBusiness
Jun 17th, 2025
Scientists present AI solution for protein folding

Scientists from the University of Sheffield, in partnership with AstraZeneca, have developed an artificial intelligence system called MapDiff, which allows for more efficient creation of proteins with a giventhree-dimensional structure and biological functions.

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC